We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $12.4B
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+2.71%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$15.1B
AUM Growth
-$207M
Cap. Flow
-$375M
Cap. Flow %
-2.48%
Top 10 Hldgs %
7.82%
Holding
1,160
New
44
Increased
363
Reduced
370
Closed
45
Avg Time Held
11 quarters
Top 10 Avg Time Held
3 quarters
Top 20 Avg Time Held
6.1 quarters

Top Sells

Rank Stock Value
1
GCO icon
Genesco
GCO
+$36.6M
2
HEI.A icon
HEICO Corp Class A
HEI.A
+$34.4M
3
FHI icon
Federated Hermes
FHI
+$31.7M
4
KFY icon
Korn Ferry
KFY
+$25.1M
5
PTC icon
PTC
PTC
+$24.2M

Sector Composition

Rank Sector Weight
1 Industrials 28.56%
2 Technology 17.98%
3 Consumer Discretionary 16.97%
4 Financials 11.66%
5 Materials 7.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CDNA icon
1001
CareDx
CDNA
$3.27B
$814K 0.01%
733,287
+206,815
+39% +$220K
2014 Q4
10 quarters
BCRX icon
1002
BioCryst Pharmaceuticals
BCRX
$2.14B
$801K 0.01%
144,000
– –
2016 Q1
5 quarters
ACGN
1003
DELISTED
Aceragen Inc
ACGN
$799K 0.01%
3,419
– –
2017 Q1
1 quarter
CNDT icon
1004
Conduent
CNDT
$232M
$797K 0.01%
50,000
– –
2017 Q1
1 quarter
ENS icon
1005
EnerSys
ENS
$6.43B
$797K 0.01%
11,000
– –
2013 Q2
16 quarters
HRTX icon
1006
Heron Therapeutics
HRTX
$78.9M
$796K 0.01%
+57,500
New +$833K
2017 Q2
0 quarters
CSLT
1007
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$785K 0.01%
189,209
-274,500
-59% -$1.07M
2016 Q3
3 quarters
ELOS
1008
DELISTED
Syneron Medical Ltd
ELOS
$758K 0.01%
69,200
– –
2013 Q2
16 quarters
CRHM
1009
DELISTED
CRH Medical Corporation
CRHM
$757K 0.01%
133,000
– –
2016 Q3
3 quarters
SPRT
1010
DELISTED
support.com, Inc.
SPRT
$754K 0.01%
322,366
– –
2013 Q2
16 quarters
BELFB icon
1011
Bel Fuse Inc Class B
BELFB
$3.44B
$747K 0.01%
30,238
– –
2013 Q2
16 quarters
CIVI icon
1012
DELISTED
Civitas Solutions, Inc.
CIVI
$742K ﹤0.01%
42,388
+7,098
+20% +$123K
2015 Q2
8 quarters
HMN icon
1013
Horace Mann Educators
HMN
$1.85B
$730K ﹤0.01%
19,300
– –
2016 Q1
5 quarters
PES
1014
DELISTED
Pioneer Energy Services Corp.
PES
$725K ﹤0.01%
353,500
+296,000
+515% +$851K
2013 Q2
16 quarters
MANH icon
1015
Manhattan Associates
MANH
$12.7B
$721K ﹤0.01%
+15,000
New +$711K
2017 Q2
0 quarters
IVTY
1016
DELISTED
Invuity, Inc
IVTY
$717K ﹤0.01%
98,939
+58,033
+142% +$451K
2016 Q4
2 quarters
HHS icon
1017
Harte-Hanks
HHS
$32.6M
$714K ﹤0.01%
69,347
-2,210
-3% -$27.9K
2013 Q2
16 quarters
CENT icon
1018
Central Garden & Pet Co
CENT
$2.56B
$709K ﹤0.01%
27,875
-62,363
-69% -$1.69M
2013 Q2
16 quarters
CBZ icon
1019
CBIZ
CBZ
$3.01B
$705K ﹤0.01%
47,000
– –
2013 Q2
16 quarters
TPR icon
1020
Tapestry
TPR
$23.4B
$705K ﹤0.01%
14,900
-14,225
-49% -$624K
2015 Q4
6 quarters
PDCO icon
1021
DELISTED
Patterson Companies, Inc.
PDCO
$704K ﹤0.01%
15,000
– –
2017 Q1
1 quarter
DBRG icon
1022
DELISTED
DigitalBridge
DBRG
$695K ﹤0.01%
12,325
– –
2016 Q3
3 quarters
PYPL icon
1023
PayPal
PYPL
$47.9B
$687K ﹤0.01%
12,800
– –
2015 Q3
7 quarters
GTN icon
1024
Gray Television
GTN
$456M
$685K ﹤0.01%
50,000
– –
2017 Q1
1 quarter
ZEUS icon
1025
DELISTED
Olympic Steel
ZEUS
$682K ﹤0.01%
35,000
– –
2013 Q2
16 quarters

Similar funds

Royce & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Royce & Associates held 1,160 positions worth $15.1B, down 1.4% from $15.3B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.

Royce & Associates's Q2 2017 filing shows 44 new, 363 increased, 370 reduced and 45 closed positions. Its largest new stake was SEACOR Marine Holdings: 1,949,741 shares worth $39.7M. The largest sale was Genesco, an estimated $36.6M.

By sector, the portfolio is most concentrated in Industrials at 29% of assets, down from 29% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Royce & Associates's largest Q2 2017 buy was SEACOR Marine Holdings: 1,949,741 shares worth $39.7M.
  • Royce & Associates added most to NETGEAR in Q2 2017, an estimated $35.6M increase.
  • Royce & Associates's biggest Q2 2017 reduction was HEICO Corp Class A, cutting an estimated $34.4M.
  • Royce & Associates fully exited Genesco in Q2 2017, selling an estimated $36.6M.
  • Royce & Associates's ten largest holdings make up 7.8% of its $15.1B portfolio in Q2 2017.
  • Royce & Associates opened 44 new positions and closed 45 in Q2 2017.
  • Royce & Associates's portfolio value fell 1.4% quarter-over-quarter to $15.1B.

Based on Royce & Associates's 13F filing for Q2 2017, filed 7 Aug 2017.